Baird lowered the firm’s price target on Sarepta (SRPT) to $15 from $21 and keeps a Neutral rating on the shares. The firm updated its model following another ESSENCE failure which is another blow to the DMD community.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT: